Pharma: Page 2

  • fda
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    3 key FDA approval trends this year

    Although approvals are off to a slow start in oncology, the agency has been living in the fast lane for neurological disorders and more.

    By Kelly Bilodeau • May 8, 2023
  • Businessman compensation
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    A biopharma CEO opens up about executive salaries — and why he wants to change the status quo

    With leaders at the biggest biopharma companies bringing in millions, the CEO of Corvus Pharmaceuticals opted for a pay cut to pour more funds into science.

    By • May 4, 2023
  • test tube gene Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Cell and gene therapies

    How the industry is overcoming hurdles in cell and gene therapy space and pushing for the next generation of treatments.

    By PharmaVoice staff
  • A paper reading "Layoff notice" in all caps sits in a yellow mailbox amongst other envelopes.
    Image attribution tooltip
    Tarathip Kwankeeree via Getty Images
    Image attribution tooltip

    Navigating workforce challenges amid a turbulent biopharma market

    A number of biopharma companies slashed their workforces this year and as market anxieties persist, more challenges could be looming.

    By • May 4, 2023
  • Neena Patil Jazz Pharmaceuticals
    Image attribution tooltip
    Permission granted by Neena Patil
    Image attribution tooltip
    Podcast

    Woman of the Week: Jazz Pharmaceuticals’ Neena Patil

    Patil’s dual interests in healthcare and law are at the intersection of her C-suite role.

    By • May 3, 2023
  • An illustration of a globe with large multicolored pins pointing to countries.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Taking your biotech global? Here’s how you can navigate cultural norms

    What’s so different about doing pharma business in the U.K. versus Japan? One of Moderna’s top brass shares her tips for navigating choppy cultural waters.

    By Alexandra Pecci • May 2, 2023
  • Professional headshot of Chris Boerner
    Image attribution tooltip
    Retrieved from Bristol Myers Squibb on April 28, 2023
    Image attribution tooltip
    Making Moves

    BMS’s CEO transition will be a major test for the pharma giant

    Come November, Chris Boerner will take the top spot as the company approaches patent cliffs for three drugs in the next decade.

    By • April 28, 2023
  • Wooden cubes that spell out "M&A"
    Image attribution tooltip
    Nastassia Samal via Getty Images
    Image attribution tooltip

    How biopharma dealmaking kicked back into action

    Events over the last year, including Pfizer’s Seagen buy and AstraZeneca’s CinCor deal, have foreshadowed the comeback of biopharma M&A.

    By • April 27, 2023
  • Daniel Cua, vice president and IL-23 pathway area leader, Janssen
    Image attribution tooltip
    Permission granted by Janssen
    Image attribution tooltip

    Pharma’s immunology field is full of blockbusters, and it’s just getting started

    From the "father" of the IL-23 pathway at Janssen to a big acquisition by Merck, the ultra-competitive immunology space is still growing with the pace of innovation.

    By • April 27, 2023
  • Professional headshot of Roy Vagelos
    Image attribution tooltip
    "P. Roy Vagelos" by Science History Institute is licensed under CC BY-SA 3.0
    Image attribution tooltip

    Roy Vagelos is retiring and leaving a legacy of leadership lessons

    The longtime pharma leader is stepping down from his role as chair of Regeneron’s board in June after decades in drug development. 

    By • April 25, 2023
  • tuberculosis scan
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Tuberculosis is the world’s deadliest infectious disease — and treatments remain underfunded

    Tuberculosis control and funding lost 20 years of progress during the COVID-19 pandemic, but scientists and world health groups are still plugging away.

    By Alexandra Pecci • April 24, 2023
  • A genome sequencing map with lines of varying colors and sizes
    Image attribution tooltip
    Olena Yepifanova via Getty Images
    Image attribution tooltip

    20 years on, the next stage of the human genome revolution is brewing

    Two decades after the Human Genome Project, scientists are on the brink of uncovering its full potential for drug development.

    By • April 24, 2023
  • Preeti Parikh, MD Executive Medical Director GoodRx
    Image attribution tooltip
    Permission granted by GoodRx
    Image attribution tooltip
    Sponsored by GoodRx

    A physician’s perspective on health equity, diversity and inclusion

    Dr. Preeti Parikh sees parallels between promoting health equity and current DE&I challenges in the workplace.

    By Preeti Parikh, MD, Executive Medical Director, GoodRx • April 24, 2023
  • Peter Kirk Sermo
    Image attribution tooltip
    Permission granted by Peter Kirk
    Image attribution tooltip
    Profile

    The 99 seconds that changed this CEO’s life

    Peter Kirk’s marathon story of inspiration and perseverance.

    By • April 21, 2023
  • Lou Tartaglia, founder and managing partner, Cure Ventures
    Image attribution tooltip
    Permission granted by Cure Ventures
    Image attribution tooltip
    Q&A

    Cure Ventures has $350M to pour deep into biotech ‘company building’

    The biotech venture capital firm Cure Ventures, led by three industry veterans, raised the inaugural fund in early April and will soon announce its seed companies.

    By • April 20, 2023
  • Chris Benecchi, chief business officer, Sage Therapeutics
    Image attribution tooltip
    Permission granted by Sage
    Image attribution tooltip
    Q&A

    Depression has long been treated chronically — Sage wants to change that

    Sage Therapeutics is planning a launch of its newest med, and its chief business officer explains how it could upend the way depression has long been treated.

    By • April 18, 2023
  • Young people sitting on the stairs and using smartphones.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Patient influencers are here to stay — where are the regulations?

    As social media health influencers enter the world of pharma advertising, experts warn that more guardrails are needed to protect the industry and patients.

    By • April 17, 2023
  • COVID vaccine development
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    A new era of COVID innovation is here

    With a $5 billion dollar infusion, a new White House program is helping catalyze development of next-gen treatments, from pan-coronavirus vaccines to enhanced antivirals. 

    By Kelly Bilodeau • April 17, 2023
  • Multi-colored panels against navy background and brand logo
    Image attribution tooltip
    Permission granted by ProtaGene
    Image attribution tooltip
    Sponsored by ProtaGene

    Overcoming Analytical Challenges for Gene Therapies

    Gain a deep understanding of the analytical challenges that gene therapy developers face, and how a strategic partnership with a specialized CRO can offer a competitive advantage in accelerating timelines and improving program success.

    By Jennifer Chadwick, Ph.D. | Chief Scientific Officer of ProtaGene • April 17, 2023
  • Vaccine
    Image attribution tooltip
    David Greedy/Getty Images via Getty Images
    Image attribution tooltip

    Fighting vaccine hesitancy may require a new approach from pharma

    The COVID-19 pandemic highlighted an ongoing problem of vaccine hesitancy undermining public health efforts. One way pharmas can help is to change the narrative.

    By • April 13, 2023
  • Julia Lakeland uMotif
    Image attribution tooltip
    Permission granted by Julia Lakeland uMotif
    Image attribution tooltip
    Podcast

    Woman of the Week: uMotif’s Julia Lakeland

    The chief product officer’s work in transforming clinical trial technology is driven by people.

    By • April 12, 2023
  • A councelor comforting her emotional patient and taking notes during therapy session.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    What’s pharma doing wrong to improve trial diversity? ‘Everything’

    Pharma’s missing the mark when it comes to recruiting Black patients, and Ricki Fairley, CEO of The Black Breast Cancer Alliance, reveals what’s needed.

    By • April 12, 2023
  • Dave Hering
    Image attribution tooltip
    Permission granted by Invivyd Therapeutics
    Image attribution tooltip
    Profile

    He helped launch the Pfizer COVID vaccine — now this startup CEO is hunting a lingering pandemic foe

    All of the COVID-19 mAbs have been pulled from the market. But Dave Hering, CEO of Invivyd, hopes to change that.

    By • April 11, 2023
  • Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip

    After working at Merck during the Vioxx scandal, this former sales rep is on a mission to fix the system

    The founder and CEO for the Accreditation Council for Medical Affairs is increasing accountability in pharma by emphasizing training, standards and ethics in medical affairs.

    By Alexandra Pecci • April 11, 2023
  • Shot of a young woman using a cellphone while relaxing at home
    Image attribution tooltip
    Adene Sanchez via Getty Images
    Image attribution tooltip
    Sponsored by GoodRx

    GoodRx Health is the one-stop-shop for patients — and marketers

    Optimize patient conversion through a single platform with GoodRx: the one-stop-shop for patients — and marketers.

    April 10, 2023
  • Peyton Howell Parexel
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip
    Q&A

    5 minutes with — Parexel’s Peyton Howell

    The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked."

    By • April 7, 2023